UBS Group’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $815K | Buy |
|
|||||
|
2025
Q2 | $474K | Buy |
|
|||||
|
2025
Q1 | $466K | Sell |
|
|||||
|
2024
Q4 | $748K | Buy |
|
|||||
|
2024
Q3 | $82.7K | Buy |
|
|||||
|
2024
Q2 | $15.8K | Sell |
|
|||||
|
2024
Q1 | $16.2K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $234 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $7K | Buy |
|
|||||
|
2022
Q1 | $14K | Sell |
|
|||||
|
2021
Q4 | $47K | Sell |
|
|||||
|
2021
Q3 | $249K | Buy |
|